Investor's Business Daily on MSN

Edgewise Therapeutics Earns Relative Strength Rating Upgrade; Hits Key Threshold

Edgewise Therapeutics posted 0% earnings growth in the latest quarterly report, while sales growth came in at 0%. The company ...